Medical and Pharmaceutical Prelude Therapeutics Incorporated shares drop 30% on clinical trial news The drug in question is also presently being tested in an ongoing dose-escalation Phase 1 trial for patients with solid tumours Joseph MortonSeptember 13, 2024
Gold B2Gold and Government of Mali come to terms on Fekola mining complex Mining operations will begin once the exploitation permit for Fekola Regional is granted Joseph MortonSeptember 13, 2024
Bitcoin India goes after big name crypto exchanges for backtaxes and regulatory noncompliance The Financial Intelligence Unit issued compliance show cause notices to nine prominent exchanges Joseph MortonSeptember 12, 2024
Technology Netgear stock soars on settlement news and stronger Q3 outlook Initially set at USD$160-175 million, the revised revenue forecast now stands at USD$170-180 million Joseph MortonSeptember 12, 2024
Copper Yukon Supreme Court gives control of Minto Mine to Selkirk First Nation The Selkirk First Nation has committed to ensuring environmental integrity for the mine Joseph MortonSeptember 12, 2024
Bitcoin The unlikely triumph of a solo Bitcoin miner in 2024 The entire energy requirement for the bitcoin network rivals somewhere between the countries of Argentina and the Netherlands Joseph MortonSeptember 11, 2024
Gold Newmont Corporation sells off non-core assets in Australia These divestitures are deeply tied to Newmont's financial strategy Joseph MortonSeptember 11, 2024
Gold African Central Banks buy gold as a hedge against unstable dollar African gold production has increased by 60 per cent since 2010, outpacing the global rise of 26 per cent Joseph MortonSeptember 11, 2024
Copper Ivanhoe Mines kickstarts potential copper exploration with deal in Zambia Ivanhoe also applied for an exploration licence package in the country expected to come by the end of 2024 Joseph MortonSeptember 10, 2024
Medical and Pharmaceutical Why are Viridian Therapeutics shares on the rise on Tuesday? Veligrotug’s response rate and metrics suggest competitive, and potentially superior, performance than drug presently on the market Joseph MortonSeptember 10, 2024